Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2182-2189.
Prepublished online as a Blood First Edition Paper on June 27, 2006; DOI 10.1182/blood-2006-01-010249.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Methods and Videos
Right arrow All Versions of this Article:
blood-2006-01-010249v1
108/7/2182    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ancliff, P. J
Right arrow Articles by Thrasher, A. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ancliff, P. J
Right arrow Articles by Thrasher, A. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted January 10, 2006
Accepted April 10, 2006

Two novel activating mutations in the Wiskott-Aldrich Syndrome protein resulting in congenital neutropenia

Phil J Ancliff*, Michael P Blundell, Giles O Cory, Yolanda Calle, Austen Worth, Helena Kempski, Siobhan Burns, Gareth E Jones, Jo Sinclair, Christine Kinnon, Ian M Hann, Rosemary E Gale, David C Linch, and Adrian J Thrasher

Department of Haematology, Great Ormond Street Hospital, London, UK
Molecular Immunology Unit, Institute of Child Health, University College London, UK
Department of Biochemistry, School of Medical Sciences, University of Bristol, UK
The Randall Centre for Molecular Mechanisms of Cell Function, King's College London, UK
Molecular Haematology Unit, Institute of Child Health, University College London, UK
The Randall Centre for Molecular
Royal Free and University College Medical School

* Corresponding author; email: anclip{at}gosh.nhs.uk.

Severe congenital neutropenia (SCN) is characterized by neutropenia, recurrent bacterial infections and maturation arrest in the bone marrow. Although many cases have mutations in the ELA2 gene encoding neutrophil elastase, a significant proportion remain undefined at a molecular level. A mutation (L270P) in the gene encoding the Wiskott-Aldrich Syndrome protein (WASp) resulting in an X-linked SCN kindred has been reported. We therefore screened the WAS gene in 14 young SCN males with wild-type ELA2 and identified two with novel mutations, one who presented with myelodysplasia (I294T) and the other with classical SCN (S272P). Both patients had defects of immunological function including a generalized reduction of lymphoid and natural killer cell numbers, reduced lymphocyte proliferation and abrogated phagocyte activity. In vitro culture of bone marrow progenitors demonstrated a profound reduction in neutrophil production and increased levels of apoptosis, consistent with an intrinsic disturbance of normal myeloid differentiation as the cause of the neutropenia. Both mutations resulted in increased WASp activity and produced marked abnormalities of cytoskeletal structure and dynamics. Furthermore, these results also suggest a novel cause of myelodysplasia and suggest that male children with myelodysplasia and disturbance of immunological function should be screened for such mutations.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
H. Park and D. Cox
Cdc42 Regulates Fc{gamma} Receptor-mediated Phagocytosis through the Activation and Phosphorylation of Wiskott-Aldrich Syndrome Protein (WASP) and Neural-WASP
Mol. Biol. Cell, November 1, 2009; 20(21): 4500 - 4508.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
C. Klein
Molecular basis of congenital neutropenia
Haematologica, October 1, 2009; 94(10): 1333 - 1336.
[Full Text] [PDF]


Home page
haematolHome page
K. Beel and P. Vandenberghe
G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia
Haematologica, October 1, 2009; 94(10): 1449 - 1452.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. P. Blundell, G. Bouma, J. Metelo, A. Worth, Y. Calle, L. A. Cowell, L. S. Westerberg, D. A. Moulding, S. Mirando, C. Kinnon, et al.
Phosphorylation of WASp is a key regulator of activity and stability in vivo
PNAS, September 15, 2009; 106(37): 15738 - 15743.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. J. Salipante, M. E. B. Rojas, B. Korkmaz, Z. Duan, J. Wechsler, K. F. Benson, R. E. Person, H. L. Grimes, and M. S. Horwitz
Contributions to Neutropenia from PFAAP5 (N4BP2L2), a Novel Protein Mediating Transcriptional Repressor Cooperation between Gfi1 and Neutrophil Elastase
Mol. Cell. Biol., August 15, 2009; 29(16): 4394 - 4405.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Bosticardo, F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome
Blood, June 18, 2009; 113(25): 6288 - 6295.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. S. Velu, A. M. Baktula, and H. L. Grimes
Gfi1 regulates miR-21 and miR-196b to control myelopoiesis
Blood, May 7, 2009; 113(19): 4720 - 4728.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. D. Notarangelo and R. Badolato
Leukocyte trafficking in primary immunodeficiencies
J. Leukoc. Biol., March 1, 2009; 85(3): 335 - 343.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. Boztug, G. Appaswamy, A. Ashikov, A. A. Schaffer, U. Salzer, J. Diestelhorst, M. Germeshausen, G. Brandes, J. Lee-Gossler, F. Noyan, et al.
A Syndrome with Congenital Neutropenia and Mutations in G6PC3
N. Engl. J. Med., January 1, 2009; 360(1): 32 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Montoya-Durango, C. S. Velu, A. Kazanjian, M. E. B. Rojas, C. M. Jay, G. D. Longmore, and H. L. Grimes
Ajuba Functions as a Histone Deacetylase-dependent Co-repressor for Autoregulation of the Growth Factor-independent-1 Transcription Factor
J. Biol. Chem., November 14, 2008; 283(46): 32056 - 32065.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G P Spickett
Immune deficiency disorders involving neutrophils
J. Clin. Pathol., September 1, 2008; 61(9): 1001 - 1005.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Berliner
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis
Blood, June 15, 2008; 111(12): 5427 - 5432.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. A. Moulding, M. P. Blundell, D. G. Spiller, M. R.H. White, G. O. Cory, Y. Calle, H. Kempski, J. Sinclair, P. J. Ancliff, C. Kinnon, et al.
Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia
J. Exp. Med., September 3, 2007; 204(9): 2213 - 2224.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. S. Horwitz, Z. Duan, B. Korkmaz, H.-H. Lee, M. E. Mealiffe, and S. J. Salipante
Neutrophil elastase in cyclic and severe congenital neutropenia
Blood, March 1, 2007; 109(5): 1817 - 1824.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020